On March 2, 2020 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported that the company plans to present at the following conferences (Press release, Iovance Biotherapeutics, MAR 2, 2020, View Source [SID1234555134]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 40th Annual Health Care Conference in Boston, March 2-4, 2020
Date/Time: Wednesday, March 4, at 8:40 a.m. EST
Webcast: a live and archived webcast of the presentation will be available in the Investors section of the Iovance website at View Source

Oppenheimer 30th Annual Healthcare Conference in New York, March 17-18, 2020
Date/Time: Tuesday, March 17, at 9:45 a.m. EDT
Webcast: a live and archived webcast of the presentation will be available in the Investors section of the Iovance website at View Source

Alliance for Cancer Gene Therapy (ACGT) Cancer Summit 2020 in New York, April 16, 2020
Date/Time: 2:15 p.m. EDT, April 16, panel discussion